Logo Annals of Transplantation Logo Annals of Transplantation Logo Annals of Transplantation

Current Volume 13(1) 2008 Supl. (48)

#880211

01 Dec 2007   

Comparing graft function for tacrolimus- and cyclosporine-treated patients. A long-term comparative study involving nephrotoxicity markers

Z. Marchewka, J. Kuźniar [...]

Ann Transplant 2008; 13(1): 43-43 :: ID: 880211

#880211

01 Dec 2007   

Comparing graft function for tacrolimus- and cyclosporine-treated patients. A long-term comparative study involving nephrotoxicity markers

Z. Marchewka, J. Kuźniar, K. Falkiewicz, B. Szymańska, M. Zynek-Litwin, D. Patrzałek, A. Długosz, M. Klinger

Ann Transplant 2008; 13(1): 43-43 :: ID: 880211

162 0

#880210

01 Dec 2007   

Drug lymphocyte level: New perspective in clinical immunosuppression monitoring

A. Barbari,

Ann Transplant 2008; 13(1): 43-43 :: ID: 880210

#880210

01 Dec 2007   

Drug lymphocyte level: New perspective in clinical immunosuppression monitoring

A. Barbari

Ann Transplant 2008; 13(1): 43-43 :: ID: 880210

164 0

#880209

01 Dec 2007   

Biomarkers assays for T-lymphocyte activation and proliferation applied in a multicenter clinical trial of AEB071 in renal transplantation

J. M. Kovarik, K. Budde [...]

Ann Transplant 2008; 13(1): 42-42 :: ID: 880209

#880209

01 Dec 2007   

Biomarkers assays for T-lymphocyte activation and proliferation applied in a multicenter clinical trial of AEB071 in renal transplantation

J. M. Kovarik, K. Budde, J. Steiger, J. M. Grinyo, F. Straube, A. Groenewegen, A. Vitalit, J. Geissler, J. Klupp, M. J. Barten

Ann Transplant 2008; 13(1): 42-42 :: ID: 880209

179 0

#880208

01 Dec 2007   

Inosine monophosphate dehydrogenase (IMPDH) activity after mycophenolate mofetil (MMF) in renal transplant patients receiving different immunosuppressive combined therapy and stable after at least 3 months’ administration

L. R. Chiarelli, M. Molinaro [...]

Ann Transplant 2008; 13(1): 42-42 :: ID: 880208

#880208

01 Dec 2007   

Inosine monophosphate dehydrogenase (IMPDH) activity after mycophenolate mofetil (MMF) in renal transplant patients receiving different immunosuppressive combined therapy and stable after at least 3 months’ administration

L. R. Chiarelli, M. Molinaro, C. Libetta, C. Tinelli, L. Cosmai, G. Valentini, A. Dal Canton, M. Regazzi

Ann Transplant 2008; 13(1): 42-42 :: ID: 880208

174 0

#880207

01 Dec 2007   

IMPDH activity on day 6 after kidney transplantation is significantly related to the risk of acute rejection in MMF treated patients

F. Sombogaard, R.A.A. Mathot [...]

Ann Transplant 2008; 13(1): 41-42 :: ID: 880207

#880207

01 Dec 2007   

IMPDH activity on day 6 after kidney transplantation is significantly related to the risk of acute rejection in MMF treated patients

F. Sombogaard, R.A.A. Mathot, P. Glander, W. Weimar, T. van Gelder

Ann Transplant 2008; 13(1): 41-42 :: ID: 880207

172 0

#880206

01 Dec 2007   

Association between pharmacodynamic parameters and clinical events under therapy with EC-MPS in the early phase after kidney transplantation (KTx)

E. Wieland, M. Shipkova [...]

Ann Transplant 2008; 13(1): 41-41 :: ID: 880206

#880206

01 Dec 2007   

Association between pharmacodynamic parameters and clinical events under therapy with EC-MPS in the early phase after kidney transplantation (KTx)

E. Wieland, M. Shipkova, Y. Martius, G. Hasche, C. Klett, R. Bolley, C. Olbricht

Ann Transplant 2008; 13(1): 41-41 :: ID: 880206

191 0

#880205

01 Dec 2007   

Tacrolimus – biotechnological prospects for a generic product

W. Gajzlerska, J. Turło [...]

Ann Transplant 2008; 13(1): 40-41 :: ID: 880205

#880205

01 Dec 2007   

Tacrolimus – biotechnological prospects for a generic product

W. Gajzlerska, J. Turło, B. Gutkowska, F. Herold

Ann Transplant 2008; 13(1): 40-41 :: ID: 880205

160 0

#880204

01 Dec 2007   

Pharmacokinetics of mycophenolic acid and its phenyl-glucuronide in kidney transplant recipients with renal insufficiency

M. Chrzanowska, J. Kamińska [...]

Ann Transplant 2008; 13(1): 40-40 :: ID: 880204

#880204

01 Dec 2007   

Pharmacokinetics of mycophenolic acid and its phenyl-glucuronide in kidney transplant recipients with renal insufficiency

M. Chrzanowska, J. Kamińska, M. Głyda, N. Wachowiak

Ann Transplant 2008; 13(1): 40-40 :: ID: 880204

152 0

#880203

01 Dec 2007   

Cyclosporine use in miscellaneous clinical settings other than organ transplantations: is there any evidence for target levels?

H. Tesfaye, R. Prusa [...]

Ann Transplant 2008; 13(1): 40-40 :: ID: 880203

#880203

01 Dec 2007   

Cyclosporine use in miscellaneous clinical settings other than organ transplantations: is there any evidence for target levels?

H. Tesfaye, R. Prusa, B. Jedlickova, J. Segethova

Ann Transplant 2008; 13(1): 40-40 :: ID: 880203

169 0

#880202

01 Dec 2007   

Therapeutic Drug Monitoring of tacrolimus in renal transplant patients

B. Solnica, K. Słowińska-Solnica [...]

Ann Transplant 2008; 13(1): 39-40 :: ID: 880202

#880202

01 Dec 2007   

Therapeutic Drug Monitoring of tacrolimus in renal transplant patients

B. Solnica, K. Słowińska-Solnica, E. Ignacak, J. W. Naskalski

Ann Transplant 2008; 13(1): 39-40 :: ID: 880202

169 0

#880201

01 Dec 2007   

Population pharmacokinetics of tacrolimus in paediatric bone marrow transplantation and implementation in a dose adaptation tool

J.E. Wallin, L. E. Friberg [...]

Ann Transplant 2008; 13(1): 39-39 :: ID: 880201

#880201

01 Dec 2007   

Population pharmacokinetics of tacrolimus in paediatric bone marrow transplantation and implementation in a dose adaptation tool

J.E. Wallin, L. E. Friberg, A. Fasth, C. E. Staatz

Ann Transplant 2008; 13(1): 39-39 :: ID: 880201

172 0

#880200

01 Dec 2007   

Conversion from tacrolimus twice a day formulation to once-daily tacrolimus in kidney transplant recipients

D. Kamińska, M. Kuriata-Kordek [...]

Ann Transplant 2008; 13(1): 38-39 :: ID: 880200

#880200

01 Dec 2007   

Conversion from tacrolimus twice a day formulation to once-daily tacrolimus in kidney transplant recipients

D. Kamińska, M. Kuriata-Kordek, M. Boratyńska, K. Falkiewicz, M. Klinger

Ann Transplant 2008; 13(1): 38-39 :: ID: 880200

161 0

#880198

01 Dec 2007   

Evaluating co-medication and matrix interference influence on ion yields: A key step in therapeutic drug monitoring HPLC-MS/MS assay validation

C. Seger, M. Bock [...]

Ann Transplant 2008; 13(1): 38-38 :: ID: 880198

#880198

01 Dec 2007   

Evaluating co-medication and matrix interference influence on ion yields: A key step in therapeutic drug monitoring HPLC-MS/MS assay validation

C. Seger, M. Bock, K. Tentschert, A. Griesmacher

Ann Transplant 2008; 13(1): 38-38 :: ID: 880198

195 0

#880199

01 Dec 2007   

Comparison of tacrolimus levels obtained with twice-daily administration formulation (Prograf®) and with once-daily formulation (Advagraf®)

M. T. Rabuñal Álvarez, E. Fernández Gabriel [...]

Ann Transplant 2008; 13(1): 38-38 :: ID: 880199

#880199

01 Dec 2007   

Comparison of tacrolimus levels obtained with twice-daily administration formulation (Prograf®) and with once-daily formulation (Advagraf®)

M. T. Rabuñal Álvarez, E. Fernández Gabriel, M. Outeda Macías, I. Martín Herranz

Ann Transplant 2008; 13(1): 38-38 :: ID: 880199

146 0

#880197

01 Dec 2007   

Evaluation of the Architect and Dimension tacrolimus and cyclosporine assays

P. Wallemacq, J. S. Goffinet [...]

Ann Transplant 2008; 13(1): 37-38 :: ID: 880197

#880197

01 Dec 2007   

Evaluation of the Architect and Dimension tacrolimus and cyclosporine assays

P. Wallemacq, J. S. Goffinet, H. Ait-Youcef

Ann Transplant 2008; 13(1): 37-38 :: ID: 880197

190 0

#880196

01 Dec 2007   

Siemens Healthcare Diagnostics immunosuppressive drug monitoring solutions

T. Wei, N. Morjana [...]

Ann Transplant 2008; 13(1): 37-37 :: ID: 880196

#880196

01 Dec 2007   

Siemens Healthcare Diagnostics immunosuppressive drug monitoring solutions

T. Wei, N. Morjana, S. Goss, L. Bantum, Y. Yue, R. Janzen, G. Siefring

Ann Transplant 2008; 13(1): 37-37 :: ID: 880196

221 0

#880195

01 Dec 2007   

Evaluation of a commercially available whole blood calibrator and control kit for the analysis of cyclosporin A, everolimus, sirolimus and tacrolimus using LC/MS/MS technology

A. M. Taylor, T. N. Gamble [...]

Ann Transplant 2008; 13(1): 36-37 :: ID: 880195

#880195

01 Dec 2007   

Evaluation of a commercially available whole blood calibrator and control kit for the analysis of cyclosporin A, everolimus, sirolimus and tacrolimus using LC/MS/MS technology

A. M. Taylor, T. N. Gamble, D. Blake, T. Drury, M. Ehrdhard

Ann Transplant 2008; 13(1): 36-37 :: ID: 880195

159 0

163 0

#880193

01 Dec 2007   

Sirolimus measurement by LC-MS/MS without solid phase extraction – overcoming the obstacles

N. W. Brown, P. Arampatzis [...]

Ann Transplant 2008; 13(1): 36-36 :: ID: 880193

#880193

01 Dec 2007   

Sirolimus measurement by LC-MS/MS without solid phase extraction – overcoming the obstacles

N. W. Brown, P. Arampatzis, C. E. Gonde, M. Pires, J. Tracey, M. Tredger

Ann Transplant 2008; 13(1): 36-36 :: ID: 880193

183 0

#880192

29 Sep 2008   

The role of genetics and pharmacogenetic monitoring in transplantation

M. Masri,

Ann Transplant 2008; 13(1): 35-35 :: ID: 880192

#880192

29 Sep 2008   

The role of genetics and pharmacogenetic monitoring in transplantation

M. Masri

Ann Transplant 2008; 13(1): 35-35 :: ID: 880192

162 0

#880191

01 Dec 2007   

The CYP3A5*1/*3 single nucleotide polymorphism (SNP) determines the extent of drug interaction between tacrolimus and fluconazole in renal transplant recipients

H. de Jonge, M. Naesens [...]

Ann Transplant 2008; 13(1): 34-35 :: ID: 880191

#880191

01 Dec 2007   

The CYP3A5*1/*3 single nucleotide polymorphism (SNP) determines the extent of drug interaction between tacrolimus and fluconazole in renal transplant recipients

H. de Jonge, M. Naesens, Y. Vanrenterghem, D. R. Kuypers

Ann Transplant 2008; 13(1): 34-35 :: ID: 880191

174 0

#880190

01 Dec 2007   

In vitro investigation of MRP 2 in the cyclosporine A – pravastatin interplay

R.l Kato, M. Nishide [...]

Ann Transplant 2008; 13(1): 34-34 :: ID: 880190

#880190

01 Dec 2007   

In vitro investigation of MRP 2 in the cyclosporine A – pravastatin interplay

R.l Kato, M. Nishide, C. Kodzu, Y. Ijiri, K. Tanaka

Ann Transplant 2008; 13(1): 34-34 :: ID: 880190

166 0

#880189

01 Dec 2007   

In vivo hepatic CYP3A4 activity is significantly higher in tacrolimus treated vs cyclosporine treated renal transplant recipients

H. de Jonge, M. Naesens [...]

Ann Transplant 2008; 13(1): 34-34 :: ID: 880189

#880189

01 Dec 2007   

In vivo hepatic CYP3A4 activity is significantly higher in tacrolimus treated vs cyclosporine treated renal transplant recipients

H. de Jonge, M. Naesens, K. Verbeke, Y. Vanrenterghem, D. R. Kuypers

Ann Transplant 2008; 13(1): 34-34 :: ID: 880189

173 0

#880188

01 Dec 2007   

The effect of CYP3A5 and ABCB1 single nucleotide polymorphisms on tacrolimus dose requirements in caucasian liver transplant patients

A. Provenzani, M. Notarbartolo [...]

Ann Transplant 2008; 13(1): 33-33 :: ID: 880188

#880188

01 Dec 2007   

The effect of CYP3A5 and ABCB1 single nucleotide polymorphisms on tacrolimus dose requirements in caucasian liver transplant patients

A. Provenzani, M. Notarbartolo, F. Biondi, M. Labbozzetta, P. Poma, G. Vizzini, U. Palazzo, P. Polidori, F. Triolo, B. Gridelli, N. D'Alessandro

Ann Transplant 2008; 13(1): 33-33 :: ID: 880188

164 0

#880187

01 Dec 2007   

The pregnane X receptor C-25385t single nucleotide polymorphism (SNP) does not affect tacrolimus pharmacokinetics in a large cohort of renal transplant recipients

H. de Jonge, M. Naesens [...]

Ann Transplant 2008; 13(1): 33-33 :: ID: 880187

#880187

01 Dec 2007   

The pregnane X receptor C-25385t single nucleotide polymorphism (SNP) does not affect tacrolimus pharmacokinetics in a large cohort of renal transplant recipients

H. de Jonge, M. Naesens, Y. Vanrenterghem, D. R. Kuypers

Ann Transplant 2008; 13(1): 33-33 :: ID: 880187

169 0

#880186

01 Dec 2007   

Modified release formulation in immunotherapy – the tacrolimus case

N. Undre,

Ann Transplant 2008; 13(1): 32-32 :: ID: 880186

#880186

01 Dec 2007   

Modified release formulation in immunotherapy – the tacrolimus case

N. Undre

Ann Transplant 2008; 13(1): 32-32 :: ID: 880186

180 0

#880185

01 Dec 2007   

Generic substitution of immunosuppressive drugs – requirements for an equivalent product

A. Johnston, D. W. Holt

Ann Transplant 2008; 13(1): 31-31 :: ID: 880185

#880185

01 Dec 2007   

Generic substitution of immunosuppressive drugs – requirements for an equivalent product

A. Johnston, D. W. Holt

Ann Transplant 2008; 13(1): 31-31 :: ID: 880185

162 0

#880184

01 Dec 2007   

Generic products – requirements for drug registration

P. K. Kunicki,

Ann Transplant 2008; 13(1): 30-30 :: ID: 880184

#880184

01 Dec 2007   

Generic products – requirements for drug registration

P. K. Kunicki

Ann Transplant 2008; 13(1): 30-30 :: ID: 880184

145 0

#880183

01 Dec 2007   

Therapeutic drug monitoring of immunosuppressive drugs – future perspectives

P. Wallemacq,

Ann Transplant 2008; 13(1): 29-29 :: ID: 880183

#880183

01 Dec 2007   

Therapeutic drug monitoring of immunosuppressive drugs – future perspectives

P. Wallemacq

Ann Transplant 2008; 13(1): 29-29 :: ID: 880183

157 0

#880182

01 Dec 2007   

Influence of interactions between immunosuppressive drugs on therapeutic drug monitoring

D. R. Kuypers,

Ann Transplant 2008; 13(1): 28-28 :: ID: 880182

#880182

01 Dec 2007   

Influence of interactions between immunosuppressive drugs on therapeutic drug monitoring

D. R. Kuypers

Ann Transplant 2008; 13(1): 28-28 :: ID: 880182

161 0

155 0

#880180

01 Dec 2007   

Therapeutic drug monitoring of sirolimus and everolimus

E.M. Billaud,

Ann Transplant 2008; 13(1): 26-26 :: ID: 880180

#880180

01 Dec 2007   

Therapeutic drug monitoring of sirolimus and everolimus

E.M. Billaud

Ann Transplant 2008; 13(1): 26-26 :: ID: 880180

161 0

#880179

01 Dec 2007   

Therapeutic drug monitoring of tacrolimus

P. Wallemacq,

Ann Transplant 2008; 13(1): 25-25 :: ID: 880179

#880179

01 Dec 2007   

Therapeutic drug monitoring of tacrolimus

P. Wallemacq

Ann Transplant 2008; 13(1): 25-25 :: ID: 880179

151 0

#880178

01 Dec 2007   

Therapeutic drug monitoring of ciclosporin

A. Johnston, D. W. Holt

Ann Transplant 2008; 13(1): 24-24 :: ID: 880178

#880178

01 Dec 2007   

Therapeutic drug monitoring of ciclosporin

A. Johnston, D. W. Holt

Ann Transplant 2008; 13(1): 24-24 :: ID: 880178

177 0

167 0

#880176

01 Dec 2007   

Clinical application of population pharmacokinetic methods developed for immunosuppressive drugs

P. Marquet,

Ann Transplant 2008; 13(1): 22-22 :: ID: 880176

#880176

01 Dec 2007   

Clinical application of population pharmacokinetic methods developed for immunosuppressive drugs

P. Marquet

Ann Transplant 2008; 13(1): 22-22 :: ID: 880176

161 0

#880175

01 Dec 2007   

What can we learn from proficiency testing of immunosuppressive drug assays?

D. W. Holt, A. Johnston

Ann Transplant 2008; 13(1): 21-21 :: ID: 880175

#880175

01 Dec 2007   

What can we learn from proficiency testing of immunosuppressive drug assays?

D. W. Holt, A. Johnston

Ann Transplant 2008; 13(1): 21-21 :: ID: 880175

143 0

#880174

01 Dec 2007   

Immunoassays for immunosuppressive drugs – benefi ts and risks

W. Steimer,

Ann Transplant 2008; 13(1): 20-20 :: ID: 880174

#880174

01 Dec 2007   

Immunoassays for immunosuppressive drugs – benefi ts and risks

W. Steimer

Ann Transplant 2008; 13(1): 20-20 :: ID: 880174

183 0

#880173

01 Dec 2007   

Review of the newest HPLC-MS/MS methods for determination of immunosuppressive drugs in clinical practice

M. Korecka,

Ann Transplant 2008; 13(1): 19-19 :: ID: 880173

#880173

01 Dec 2007   

Review of the newest HPLC-MS/MS methods for determination of immunosuppressive drugs in clinical practice

M. Korecka

Ann Transplant 2008; 13(1): 19-19 :: ID: 880173

141 0

169 0

#880171

01 Dec 2007   

Biomarkers - as an adjunct to immunosuppressive drug monitoring

M. Oellerich,

Ann Transplant 2008; 13(1): 17-17 :: ID: 880171

#880171

01 Dec 2007   

Biomarkers - as an adjunct to immunosuppressive drug monitoring

M. Oellerich

Ann Transplant 2008; 13(1): 17-17 :: ID: 880171

226 0

#880170

01 Dec 2007   

PK/PD modelling of immunosuppressive agents

E. Wyska,

Ann Transplant 2008; 13(1): 16-16 :: ID: 880170

#880170

01 Dec 2007   

PK/PD modelling of immunosuppressive agents

E. Wyska

Ann Transplant 2008; 13(1): 16-16 :: ID: 880170

181 0

#880169

01 Dec 2007   

Drug transporters for immunosuppressive agents

I.A.M. MacPhee,

Ann Transplant 2008; 13(1): 15-15 :: ID: 880169

#880169

01 Dec 2007   

Drug transporters for immunosuppressive agents

I.A.M. MacPhee

Ann Transplant 2008; 13(1): 15-15 :: ID: 880169

134 0

#880168

01 Dec 2007   

Pharmacogenetics in immunotherapy: present knowledge and future perspectives

D. A. Hesselink,

Ann Transplant 2008; 13(1): 13-14 :: ID: 880168

#880168

01 Dec 2007   

Pharmacogenetics in immunotherapy: present knowledge and future perspectives

D. A. Hesselink

Ann Transplant 2008; 13(1): 13-14 :: ID: 880168

212 0

#880167

01 Dec 2007   

Pharmacokinetic principles of immunosuppressive-drugs

K. Budde, P. Glander

Ann Transplant 2008; 13(1): 12-12 :: ID: 880167

#880167

01 Dec 2007   

Pharmacokinetic principles of immunosuppressive-drugs

K. Budde, P. Glander

Ann Transplant 2008; 13(1): 12-12 :: ID: 880167

169 0

#880166

01 Dec 2007   

Clinical immunosuppression – current status

M. Klinger,

Ann Transplant 2008; 13(1): 11-11 :: ID: 880166

#880166

01 Dec 2007   

Clinical immunosuppression – current status

M. Klinger

Ann Transplant 2008; 13(1): 11-11 :: ID: 880166

183 0

#880165

01 Dec 2007   

New insight of immunosuppressive drugs related nephrotoxicity

E. Thervet,

Ann Transplant 2008; 13(1): 10-10 :: ID: 880165

#880165

01 Dec 2007   

New insight of immunosuppressive drugs related nephrotoxicity

E. Thervet

Ann Transplant 2008; 13(1): 10-10 :: ID: 880165

188 0

#880164

01 Dec 2007   

Organ transplantation in Poland

M. Durlik,

Ann Transplant 2008; 13(1): 9-9 :: ID: 880164

#880164

01 Dec 2007   

Organ transplantation in Poland

M. Durlik

Ann Transplant 2008; 13(1): 9-9 :: ID: 880164

193 0

Volume 13(1) 2008 Supl. (48) Supplement

#880210

01 Dec 2007 :   

Drug lymphocyte level: New perspective in clinical immunosuppression monitoring

A. Barbari,

Ann Transplant 2008; 13(1): 43-43 :: ID: 880210

164 0

#880210

01 Dec 2007 :   

Drug lymphocyte level: New perspective in clinical immunosuppression monitoring

A. Barbari

Ann Transplant 2008; 13(1): 43-43 :: ID: 880210

164 0

#880211

01 Dec 2007 :   

Comparing graft function for tacrolimus- and cyclosporine-treated patients. A long-term comparative study involving nephrotoxicity markers

Z. Marchewka, J. Kuźniar [...]

Ann Transplant 2008; 13(1): 43-43 :: ID: 880211

162 0

#880211

01 Dec 2007 :   

Comparing graft function for tacrolimus- and cyclosporine-treated patients. A long-term comparative study involving nephrotoxicity markers

Z. Marchewka, J. Kuźniar, K. Falkiewicz, B. Szymańska, M. Zynek-Litwin, D. Patrzałek, A. Długosz, M. Klinger

Ann Transplant 2008; 13(1): 43-43 :: ID: 880211

162 0

#880208

01 Dec 2007 :   

Inosine monophosphate dehydrogenase (IMPDH) activity after mycophenolate mofetil (MMF) in renal transplant patients receiving different immunosuppressive combined therapy and stable after at least 3 months’ administration

L. R. Chiarelli, M. Molinaro [...]

Ann Transplant 2008; 13(1): 42-42 :: ID: 880208

174 0

#880208

01 Dec 2007 :   

Inosine monophosphate dehydrogenase (IMPDH) activity after mycophenolate mofetil (MMF) in renal transplant patients receiving different immunosuppressive combined therapy and stable after at least 3 months’ administration

L. R. Chiarelli, M. Molinaro, C. Libetta, C. Tinelli, L. Cosmai, G. Valentini, A. Dal Canton, M. Regazzi

Ann Transplant 2008; 13(1): 42-42 :: ID: 880208

174 0

#880209

01 Dec 2007 :   

Biomarkers assays for T-lymphocyte activation and proliferation applied in a multicenter clinical trial of AEB071 in renal transplantation

J. M. Kovarik, K. Budde [...]

Ann Transplant 2008; 13(1): 42-42 :: ID: 880209

179 0

#880209

01 Dec 2007 :   

Biomarkers assays for T-lymphocyte activation and proliferation applied in a multicenter clinical trial of AEB071 in renal transplantation

J. M. Kovarik, K. Budde, J. Steiger, J. M. Grinyo, F. Straube, A. Groenewegen, A. Vitalit, J. Geissler, J. Klupp, M. J. Barten

Ann Transplant 2008; 13(1): 42-42 :: ID: 880209

179 0

#880206

01 Dec 2007 :   

Association between pharmacodynamic parameters and clinical events under therapy with EC-MPS in the early phase after kidney transplantation (KTx)

E. Wieland, M. Shipkova [...]

Ann Transplant 2008; 13(1): 41-41 :: ID: 880206

191 0

#880206

01 Dec 2007 :   

Association between pharmacodynamic parameters and clinical events under therapy with EC-MPS in the early phase after kidney transplantation (KTx)

E. Wieland, M. Shipkova, Y. Martius, G. Hasche, C. Klett, R. Bolley, C. Olbricht

Ann Transplant 2008; 13(1): 41-41 :: ID: 880206

191 0

#880207

01 Dec 2007 :   

IMPDH activity on day 6 after kidney transplantation is significantly related to the risk of acute rejection in MMF treated patients

F. Sombogaard, R.A.A. Mathot [...]

Ann Transplant 2008; 13(1): 41-42 :: ID: 880207

172 0

#880207

01 Dec 2007 :   

IMPDH activity on day 6 after kidney transplantation is significantly related to the risk of acute rejection in MMF treated patients

F. Sombogaard, R.A.A. Mathot, P. Glander, W. Weimar, T. van Gelder

Ann Transplant 2008; 13(1): 41-42 :: ID: 880207

172 0

#880203

01 Dec 2007 :   

Cyclosporine use in miscellaneous clinical settings other than organ transplantations: is there any evidence for target levels?

H. Tesfaye, R. Prusa [...]

Ann Transplant 2008; 13(1): 40-40 :: ID: 880203

169 0

#880203

01 Dec 2007 :   

Cyclosporine use in miscellaneous clinical settings other than organ transplantations: is there any evidence for target levels?

H. Tesfaye, R. Prusa, B. Jedlickova, J. Segethova

Ann Transplant 2008; 13(1): 40-40 :: ID: 880203

169 0

#880204

01 Dec 2007 :   

Pharmacokinetics of mycophenolic acid and its phenyl-glucuronide in kidney transplant recipients with renal insufficiency

M. Chrzanowska, J. Kamińska [...]

Ann Transplant 2008; 13(1): 40-40 :: ID: 880204

152 0

#880204

01 Dec 2007 :   

Pharmacokinetics of mycophenolic acid and its phenyl-glucuronide in kidney transplant recipients with renal insufficiency

M. Chrzanowska, J. Kamińska, M. Głyda, N. Wachowiak

Ann Transplant 2008; 13(1): 40-40 :: ID: 880204

152 0

#880205

01 Dec 2007 :   

Tacrolimus – biotechnological prospects for a generic product

W. Gajzlerska, J. Turło [...]

Ann Transplant 2008; 13(1): 40-41 :: ID: 880205

160 0

#880205

01 Dec 2007 :   

Tacrolimus – biotechnological prospects for a generic product

W. Gajzlerska, J. Turło, B. Gutkowska, F. Herold

Ann Transplant 2008; 13(1): 40-41 :: ID: 880205

160 0

#880201

01 Dec 2007 :   

Population pharmacokinetics of tacrolimus in paediatric bone marrow transplantation and implementation in a dose adaptation tool

J.E. Wallin, L. E. Friberg [...]

Ann Transplant 2008; 13(1): 39-39 :: ID: 880201

172 0

#880201

01 Dec 2007 :   

Population pharmacokinetics of tacrolimus in paediatric bone marrow transplantation and implementation in a dose adaptation tool

J.E. Wallin, L. E. Friberg, A. Fasth, C. E. Staatz

Ann Transplant 2008; 13(1): 39-39 :: ID: 880201

172 0

#880202

01 Dec 2007 :   

Therapeutic Drug Monitoring of tacrolimus in renal transplant patients

B. Solnica, K. Słowińska-Solnica [...]

Ann Transplant 2008; 13(1): 39-40 :: ID: 880202

169 0

#880202

01 Dec 2007 :   

Therapeutic Drug Monitoring of tacrolimus in renal transplant patients

B. Solnica, K. Słowińska-Solnica, E. Ignacak, J. W. Naskalski

Ann Transplant 2008; 13(1): 39-40 :: ID: 880202

169 0

#880198

01 Dec 2007 :   

Evaluating co-medication and matrix interference influence on ion yields: A key step in therapeutic drug monitoring HPLC-MS/MS assay validation

C. Seger, M. Bock [...]

Ann Transplant 2008; 13(1): 38-38 :: ID: 880198

195 0

#880198

01 Dec 2007 :   

Evaluating co-medication and matrix interference influence on ion yields: A key step in therapeutic drug monitoring HPLC-MS/MS assay validation

C. Seger, M. Bock, K. Tentschert, A. Griesmacher

Ann Transplant 2008; 13(1): 38-38 :: ID: 880198

195 0

#880199

01 Dec 2007 :   

Comparison of tacrolimus levels obtained with twice-daily administration formulation (Prograf®) and with once-daily formulation (Advagraf®)

M. T. Rabuñal Álvarez, E. Fernández Gabriel [...]

Ann Transplant 2008; 13(1): 38-38 :: ID: 880199

146 0

#880199

01 Dec 2007 :   

Comparison of tacrolimus levels obtained with twice-daily administration formulation (Prograf®) and with once-daily formulation (Advagraf®)

M. T. Rabuñal Álvarez, E. Fernández Gabriel, M. Outeda Macías, I. Martín Herranz

Ann Transplant 2008; 13(1): 38-38 :: ID: 880199

146 0

#880200

01 Dec 2007 :   

Conversion from tacrolimus twice a day formulation to once-daily tacrolimus in kidney transplant recipients

D. Kamińska, M. Kuriata-Kordek [...]

Ann Transplant 2008; 13(1): 38-39 :: ID: 880200

161 0

#880200

01 Dec 2007 :   

Conversion from tacrolimus twice a day formulation to once-daily tacrolimus in kidney transplant recipients

D. Kamińska, M. Kuriata-Kordek, M. Boratyńska, K. Falkiewicz, M. Klinger

Ann Transplant 2008; 13(1): 38-39 :: ID: 880200

161 0

#880196

01 Dec 2007 :   

Siemens Healthcare Diagnostics immunosuppressive drug monitoring solutions

T. Wei, N. Morjana [...]

Ann Transplant 2008; 13(1): 37-37 :: ID: 880196

221 0

#880196

01 Dec 2007 :   

Siemens Healthcare Diagnostics immunosuppressive drug monitoring solutions

T. Wei, N. Morjana, S. Goss, L. Bantum, Y. Yue, R. Janzen, G. Siefring

Ann Transplant 2008; 13(1): 37-37 :: ID: 880196

221 0

#880197

01 Dec 2007 :   

Evaluation of the Architect and Dimension tacrolimus and cyclosporine assays

P. Wallemacq, J. S. Goffinet [...]

Ann Transplant 2008; 13(1): 37-38 :: ID: 880197

190 0

#880197

01 Dec 2007 :   

Evaluation of the Architect and Dimension tacrolimus and cyclosporine assays

P. Wallemacq, J. S. Goffinet, H. Ait-Youcef

Ann Transplant 2008; 13(1): 37-38 :: ID: 880197

190 0

#880193

01 Dec 2007 :   

Sirolimus measurement by LC-MS/MS without solid phase extraction – overcoming the obstacles

N. W. Brown, P. Arampatzis [...]

Ann Transplant 2008; 13(1): 36-36 :: ID: 880193

183 0

#880193

01 Dec 2007 :   

Sirolimus measurement by LC-MS/MS without solid phase extraction – overcoming the obstacles

N. W. Brown, P. Arampatzis, C. E. Gonde, M. Pires, J. Tracey, M. Tredger

Ann Transplant 2008; 13(1): 36-36 :: ID: 880193

183 0

#880195

01 Dec 2007 :   

Evaluation of a commercially available whole blood calibrator and control kit for the analysis of cyclosporin A, everolimus, sirolimus and tacrolimus using LC/MS/MS technology

A. M. Taylor, T. N. Gamble [...]

Ann Transplant 2008; 13(1): 36-37 :: ID: 880195

159 0

#880195

01 Dec 2007 :   

Evaluation of a commercially available whole blood calibrator and control kit for the analysis of cyclosporin A, everolimus, sirolimus and tacrolimus using LC/MS/MS technology

A. M. Taylor, T. N. Gamble, D. Blake, T. Drury, M. Ehrdhard

Ann Transplant 2008; 13(1): 36-37 :: ID: 880195

159 0

#880192

29 Sep 2008 :   

The role of genetics and pharmacogenetic monitoring in transplantation

M. Masri,

Ann Transplant 2008; 13(1): 35-35 :: ID: 880192

162 0

#880192

29 Sep 2008 :   

The role of genetics and pharmacogenetic monitoring in transplantation

M. Masri

Ann Transplant 2008; 13(1): 35-35 :: ID: 880192

162 0

#880189

01 Dec 2007 :   

In vivo hepatic CYP3A4 activity is significantly higher in tacrolimus treated vs cyclosporine treated renal transplant recipients

H. de Jonge, M. Naesens [...]

Ann Transplant 2008; 13(1): 34-34 :: ID: 880189

173 0

#880189

01 Dec 2007 :   

In vivo hepatic CYP3A4 activity is significantly higher in tacrolimus treated vs cyclosporine treated renal transplant recipients

H. de Jonge, M. Naesens, K. Verbeke, Y. Vanrenterghem, D. R. Kuypers

Ann Transplant 2008; 13(1): 34-34 :: ID: 880189

173 0

#880190

01 Dec 2007 :   

In vitro investigation of MRP 2 in the cyclosporine A – pravastatin interplay

R.l Kato, M. Nishide [...]

Ann Transplant 2008; 13(1): 34-34 :: ID: 880190

166 0

#880190

01 Dec 2007 :   

In vitro investigation of MRP 2 in the cyclosporine A – pravastatin interplay

R.l Kato, M. Nishide, C. Kodzu, Y. Ijiri, K. Tanaka

Ann Transplant 2008; 13(1): 34-34 :: ID: 880190

166 0

#880191

01 Dec 2007 :   

The CYP3A5*1/*3 single nucleotide polymorphism (SNP) determines the extent of drug interaction between tacrolimus and fluconazole in renal transplant recipients

H. de Jonge, M. Naesens [...]

Ann Transplant 2008; 13(1): 34-35 :: ID: 880191

174 0

#880191

01 Dec 2007 :   

The CYP3A5*1/*3 single nucleotide polymorphism (SNP) determines the extent of drug interaction between tacrolimus and fluconazole in renal transplant recipients

H. de Jonge, M. Naesens, Y. Vanrenterghem, D. R. Kuypers

Ann Transplant 2008; 13(1): 34-35 :: ID: 880191

174 0

#880187

01 Dec 2007 :   

The pregnane X receptor C-25385t single nucleotide polymorphism (SNP) does not affect tacrolimus pharmacokinetics in a large cohort of renal transplant recipients

H. de Jonge, M. Naesens [...]

Ann Transplant 2008; 13(1): 33-33 :: ID: 880187

169 0

#880187

01 Dec 2007 :   

The pregnane X receptor C-25385t single nucleotide polymorphism (SNP) does not affect tacrolimus pharmacokinetics in a large cohort of renal transplant recipients

H. de Jonge, M. Naesens, Y. Vanrenterghem, D. R. Kuypers

Ann Transplant 2008; 13(1): 33-33 :: ID: 880187

169 0

#880188

01 Dec 2007 :   

The effect of CYP3A5 and ABCB1 single nucleotide polymorphisms on tacrolimus dose requirements in caucasian liver transplant patients

A. Provenzani, M. Notarbartolo [...]

Ann Transplant 2008; 13(1): 33-33 :: ID: 880188

164 0

#880188

01 Dec 2007 :   

The effect of CYP3A5 and ABCB1 single nucleotide polymorphisms on tacrolimus dose requirements in caucasian liver transplant patients

A. Provenzani, M. Notarbartolo, F. Biondi, M. Labbozzetta, P. Poma, G. Vizzini, U. Palazzo, P. Polidori, F. Triolo, B. Gridelli, N. D'Alessandro

Ann Transplant 2008; 13(1): 33-33 :: ID: 880188

164 0

#880186

01 Dec 2007 :   

Modified release formulation in immunotherapy – the tacrolimus case

N. Undre,

Ann Transplant 2008; 13(1): 32-32 :: ID: 880186

180 0

#880186

01 Dec 2007 :   

Modified release formulation in immunotherapy – the tacrolimus case

N. Undre

Ann Transplant 2008; 13(1): 32-32 :: ID: 880186

180 0

#880185

01 Dec 2007 :   

Generic substitution of immunosuppressive drugs – requirements for an equivalent product

A. Johnston, D. W. Holt

Ann Transplant 2008; 13(1): 31-31 :: ID: 880185

162 0

#880185

01 Dec 2007 :   

Generic substitution of immunosuppressive drugs – requirements for an equivalent product

A. Johnston, D. W. Holt

Ann Transplant 2008; 13(1): 31-31 :: ID: 880185

162 0

#880184

01 Dec 2007 :   

Generic products – requirements for drug registration

P. K. Kunicki,

Ann Transplant 2008; 13(1): 30-30 :: ID: 880184

145 0

#880184

01 Dec 2007 :   

Generic products – requirements for drug registration

P. K. Kunicki

Ann Transplant 2008; 13(1): 30-30 :: ID: 880184

145 0

#880183

01 Dec 2007 :   

Therapeutic drug monitoring of immunosuppressive drugs – future perspectives

P. Wallemacq,

Ann Transplant 2008; 13(1): 29-29 :: ID: 880183

157 0

#880183

01 Dec 2007 :   

Therapeutic drug monitoring of immunosuppressive drugs – future perspectives

P. Wallemacq

Ann Transplant 2008; 13(1): 29-29 :: ID: 880183

157 0

#880182

01 Dec 2007 :   

Influence of interactions between immunosuppressive drugs on therapeutic drug monitoring

D. R. Kuypers,

Ann Transplant 2008; 13(1): 28-28 :: ID: 880182

161 0

#880182

01 Dec 2007 :   

Influence of interactions between immunosuppressive drugs on therapeutic drug monitoring

D. R. Kuypers

Ann Transplant 2008; 13(1): 28-28 :: ID: 880182

161 0

#880180

01 Dec 2007 :   

Therapeutic drug monitoring of sirolimus and everolimus

E.M. Billaud,

Ann Transplant 2008; 13(1): 26-26 :: ID: 880180

161 0

#880180

01 Dec 2007 :   

Therapeutic drug monitoring of sirolimus and everolimus

E.M. Billaud

Ann Transplant 2008; 13(1): 26-26 :: ID: 880180

161 0

#880179

01 Dec 2007 :   

Therapeutic drug monitoring of tacrolimus

P. Wallemacq,

Ann Transplant 2008; 13(1): 25-25 :: ID: 880179

151 0

#880179

01 Dec 2007 :   

Therapeutic drug monitoring of tacrolimus

P. Wallemacq

Ann Transplant 2008; 13(1): 25-25 :: ID: 880179

151 0

#880178

01 Dec 2007 :   

Therapeutic drug monitoring of ciclosporin

A. Johnston, D. W. Holt

Ann Transplant 2008; 13(1): 24-24 :: ID: 880178

177 0

#880178

01 Dec 2007 :   

Therapeutic drug monitoring of ciclosporin

A. Johnston, D. W. Holt

Ann Transplant 2008; 13(1): 24-24 :: ID: 880178

177 0

#880177

01 Dec 2007 :   

Development of a predictive limited sampling strategy for estimation of mycophenolic acid area under the curve in patients receiving concomitant sirolimus or cyclosporine

L. M. Shaw, M. Figurski, M. D. Pescovitz

Ann Transplant 2008; 13(1): 23-23 :: ID: 880177

167 0

#880176

01 Dec 2007 :   

Clinical application of population pharmacokinetic methods developed for immunosuppressive drugs

P. Marquet,

Ann Transplant 2008; 13(1): 22-22 :: ID: 880176

161 0

#880176

01 Dec 2007 :   

Clinical application of population pharmacokinetic methods developed for immunosuppressive drugs

P. Marquet

Ann Transplant 2008; 13(1): 22-22 :: ID: 880176

161 0

#880175

01 Dec 2007 :   

What can we learn from proficiency testing of immunosuppressive drug assays?

D. W. Holt, A. Johnston

Ann Transplant 2008; 13(1): 21-21 :: ID: 880175

143 0

#880175

01 Dec 2007 :   

What can we learn from proficiency testing of immunosuppressive drug assays?

D. W. Holt, A. Johnston

Ann Transplant 2008; 13(1): 21-21 :: ID: 880175

143 0

#880174

01 Dec 2007 :   

Immunoassays for immunosuppressive drugs – benefi ts and risks

W. Steimer,

Ann Transplant 2008; 13(1): 20-20 :: ID: 880174

183 0

#880174

01 Dec 2007 :   

Immunoassays for immunosuppressive drugs – benefi ts and risks

W. Steimer

Ann Transplant 2008; 13(1): 20-20 :: ID: 880174

183 0

#880173

01 Dec 2007 :   

Review of the newest HPLC-MS/MS methods for determination of immunosuppressive drugs in clinical practice

M. Korecka,

Ann Transplant 2008; 13(1): 19-19 :: ID: 880173

141 0

#880173

01 Dec 2007 :   

Review of the newest HPLC-MS/MS methods for determination of immunosuppressive drugs in clinical practice

M. Korecka

Ann Transplant 2008; 13(1): 19-19 :: ID: 880173

141 0

#880171

01 Dec 2007 :   

Biomarkers - as an adjunct to immunosuppressive drug monitoring

M. Oellerich,

Ann Transplant 2008; 13(1): 17-17 :: ID: 880171

226 0

#880171

01 Dec 2007 :   

Biomarkers - as an adjunct to immunosuppressive drug monitoring

M. Oellerich

Ann Transplant 2008; 13(1): 17-17 :: ID: 880171

226 0

#880170

01 Dec 2007 :   

PK/PD modelling of immunosuppressive agents

E. Wyska,

Ann Transplant 2008; 13(1): 16-16 :: ID: 880170

181 0

#880170

01 Dec 2007 :   

PK/PD modelling of immunosuppressive agents

E. Wyska

Ann Transplant 2008; 13(1): 16-16 :: ID: 880170

181 0

#880169

01 Dec 2007 :   

Drug transporters for immunosuppressive agents

I.A.M. MacPhee,

Ann Transplant 2008; 13(1): 15-15 :: ID: 880169

134 0

#880169

01 Dec 2007 :   

Drug transporters for immunosuppressive agents

I.A.M. MacPhee

Ann Transplant 2008; 13(1): 15-15 :: ID: 880169

134 0

#880168

01 Dec 2007 :   

Pharmacogenetics in immunotherapy: present knowledge and future perspectives

D. A. Hesselink,

Ann Transplant 2008; 13(1): 13-14 :: ID: 880168

212 0

#880168

01 Dec 2007 :   

Pharmacogenetics in immunotherapy: present knowledge and future perspectives

D. A. Hesselink

Ann Transplant 2008; 13(1): 13-14 :: ID: 880168

212 0

#880167

01 Dec 2007 :   

Pharmacokinetic principles of immunosuppressive-drugs

K. Budde, P. Glander

Ann Transplant 2008; 13(1): 12-12 :: ID: 880167

169 0

#880167

01 Dec 2007 :   

Pharmacokinetic principles of immunosuppressive-drugs

K. Budde, P. Glander

Ann Transplant 2008; 13(1): 12-12 :: ID: 880167

169 0

#880166

01 Dec 2007 :   

Clinical immunosuppression – current status

M. Klinger,

Ann Transplant 2008; 13(1): 11-11 :: ID: 880166

183 0

#880166

01 Dec 2007 :   

Clinical immunosuppression – current status

M. Klinger

Ann Transplant 2008; 13(1): 11-11 :: ID: 880166

183 0

#880165

01 Dec 2007 :   

New insight of immunosuppressive drugs related nephrotoxicity

E. Thervet,

Ann Transplant 2008; 13(1): 10-10 :: ID: 880165

188 0

#880165

01 Dec 2007 :   

New insight of immunosuppressive drugs related nephrotoxicity

E. Thervet

Ann Transplant 2008; 13(1): 10-10 :: ID: 880165

188 0

#880164

01 Dec 2007 :   

Organ transplantation in Poland

M. Durlik,

Ann Transplant 2008; 13(1): 9-9 :: ID: 880164

193 0

#880164

01 Dec 2007 :   

Organ transplantation in Poland

M. Durlik

Ann Transplant 2008; 13(1): 9-9 :: ID: 880164

193 0

In Press

02 Jun 2023 : Original article  

Survival analysis of transplant-associated thrombotic microangiopathy under different diagnostic criteria a...

Ann Transplant In Press; DOI: 10.12659/AOT.939890  

17 May 2023 : Original article  

Results of Liver Retransplantation After Rescue Hepatectomy: A Single-Center Study

Ann Transplant In Press; DOI: 10.12659/AOT.939557  

10 May 2023 : Original article  

Incidence of Thromboembolic Complications Following Kidney Transplantation with Short and Extended Aspirin ...

Ann Transplant In Press; DOI: 10.12659/AOT.939143  

Most Viewed Current Articles

24 Aug 2021 : Review article  

Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future Perspectives

DOI :10.12659/AOT.931664

Ann Transplant 2021; 26:e931664

26 Jan 2022 : Review article  

Recurrence of Hepatocellular Carcinoma After Liver Transplantation: Risk Factors and Predictive Models

DOI :10.12659/AOT.934924

Ann Transplant 2022; 27:e934924

29 Dec 2021 : Original article  

Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...

DOI :10.12659/AOT.933588

Ann Transplant 2021; 26:e933588

15 Mar 2022 : Case report  

Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...

DOI :10.12659/AOT.935860

Ann Transplant 2022; 27:e935860

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Annals of Transplantation eISSN: 2329-0358
Annals of Transplantation eISSN: 2329-0358